The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia
Open Access
- 20 April 2016
- journal article
- other
- Published by Wiley in British Journal of Haematology
- Vol. 176 (6), 991-994
- https://doi.org/10.1111/bjh.14024
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Guidelines for the diagnosis and management of adult aplastic anaemiaBritish Journal of Haematology, 2015
- Somatic Mutations and Clonal Hematopoiesis in Aplastic AnemiaThe New England Journal of Medicine, 2015
- Treatment of Immune Thrombocytopenia in Adults: The Role of Thrombopoietin-Receptor AgonistsSeminars in Hematology, 2015
- Eltrombopag: a stem cell cookie?Blood, 2014
- Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drugBlood, 2014
- Eltrombopag-Associated HyperpigmentationJAMA Dermatology, 2013
- How I treat acquired aplastic anemiaBlood, 2012
- Eltrombopag and Improved Hematopoiesis in Refractory Aplastic AnemiaThe New England Journal of Medicine, 2012
- Population Pharmacokinetics of Eltrombopag in Healthy Subjects and Patients With Chronic Idiopathic Thrombocytopenic PurpuraThe Journal of Clinical Pharmacology, 2011
- Flow Cytometric Measurement of Glycosylphosphatidyl-inositol-linked Surface Proteins on Blood Cells of Patients with Paroxysmal Nocturnal HemoglobinuriaAmerican Journal of Clinical Pathology, 1994